CK18F, sCD25, and sCD95 kinetics during 16 GVHD episodes
Marker . | CK18F . | sCD25 . | sCD95 . |
---|---|---|---|
Individual baseline (before SCT), median (range) | 176 (81-275) | 2832 (1130-10000) | 1142 (677-2666) |
Maximum during GVHD, median (range) | 773 (427-6880) | 10386 (238-53155) | 1832 (763-6506) |
Fold increase, estimate (95% CI) | 5.0 (3.5-6.5) | 2.7 (0.4-5.0) | 1.8 (0.5-3.0) |
P | < .001 | .04 | < .001 |
Marker . | CK18F . | sCD25 . | sCD95 . |
---|---|---|---|
Individual baseline (before SCT), median (range) | 176 (81-275) | 2832 (1130-10000) | 1142 (677-2666) |
Maximum during GVHD, median (range) | 773 (427-6880) | 10386 (238-53155) | 1832 (763-6506) |
Fold increase, estimate (95% CI) | 5.0 (3.5-6.5) | 2.7 (0.4-5.0) | 1.8 (0.5-3.0) |
P | < .001 | .04 | < .001 |
CK18F medians and ranges are in U/L; sCD25 and sCD95 medians and ranges are in pg/mL. P values are in comparison to baseline (before GVHD) using a paired t test.